How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a First-In-Class, Dual Bifunctional Degrader of CDK4/6

calendar_today May 7, 2024 person biotheryx domain biotheryx

SAN DIEGO, CA. May 7, 2024 — Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein[…] Read More

open_in_new Read original post

Discovery

Learnings

Guidance

Toolbox

Alignment

API Evangelist LLC

Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a First-In-Class, Dual Bifunctional Degrader of CDK4/6